Abstract
Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.
Keywords:
COVID-19; California; Coronavirus diseases; ICU; SARS-CoV-2; United States; coronavirus disease; hospitalization; mortality; outcomes; pneumonia; respiratory diseases; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
Publication types
-
Observational Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adenosine Monophosphate / analogs & derivatives
-
Adenosine Monophosphate / therapeutic use
-
Aged
-
Aged, 80 and over
-
Alanine / analogs & derivatives
-
Alanine / therapeutic use
-
Asthma / epidemiology
-
Asthma / physiopathology
-
Azithromycin / therapeutic use
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
COVID-19 Testing
-
California / epidemiology
-
Clinical Laboratory Techniques / methods
-
Comorbidity
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / mortality
-
Diabetes Mellitus / epidemiology*
-
Diabetes Mellitus / physiopathology
-
Female
-
Humans
-
Hyperlipidemias / epidemiology*
-
Hyperlipidemias / physiopathology
-
Hypertension / epidemiology*
-
Hypertension / physiopathology
-
Intensive Care Units
-
Length of Stay
-
Male
-
Pandemics*
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / mortality
-
Pulmonary Disease, Chronic Obstructive / epidemiology
-
Pulmonary Disease, Chronic Obstructive / physiopathology
-
Retrospective Studies
-
Reverse Transcriptase Polymerase Chain Reaction
-
SARS-CoV-2
-
Severity of Illness Index
-
Survival Analysis
-
Tomography, X-Ray Computed
Substances
-
remdesivir
-
Adenosine Monophosphate
-
Azithromycin
-
Alanine